The emerging functional diversity of RNA-responsive Cas12 systems, including Cas12a, Cas12a2, Cas12a3, Cas12f, and Cas12g, are summarized and their underlying mechanisms for direct RNA sensing are discussed, alongside key challenges and future opportunities for clinical translation and point-of-care testing.
Tim Hall, Zheng-Yang Jia, Kong-Zhen Cai et al.· Critical reviews in analytic...· 0 citations
KRAS mutations, including G12D, G12V and G13D, are major oncogenic drivers in colorectal cancer (CRC) and are associated with therapeutic resistance. However, approved KRAS inhibitors remain focused on G12C subtype, leaving these prevalent variants without approved targeted therapies. Here, we developed a lipid nanopar...
Yu-Hang Wang, Shu-Quan Su, Kainat Zahra et al.· bioRxiv· 0 citations
This study developed lipid-based nanoparticles to release Cas9/sgRNA ribonucleoprotein (RNP) complexes under light illumination, enabling light-controlled editing of the VEGFA gene, providing a foundation for spatially controlled VEGFA genome editing as a potential therapeutic strategy for VEGFA-driven macular neovascu...
Rui Sang, Xin-Pu Yang, Ewa M. Goldys et al.· bioRxiv· 0 citations
Abstract DNA and RNA methylation are key epigenetic and epitranscriptomic modifications involved in gene regulation, genome stability, RNA metabolism, and disease progression. Aberrant methylation patterns in cell‐free DNA and RNA have emerged as valuable biomarkers for cancer detection, disease monitoring, and therape...
Kai-Xin Chen, Bi-Yao Yang, Rui Sang et al.· Bioengineering & Translation...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.